• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis.

广告
作者单位: Cancer Science Institute of Singapore, National University of Singapore, Singapore. [1] Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [2] Department of Laboratory Medicine, Molecular Diagnosis Centre, National University Health System, Singapore. [3] Department of Laboratory Medicine, Molecular Diagnosis Centre, National University Health System, Singapore, Singapore. [4] School of Life Science and Technology, Tongji University, Shanghai, China. [5] Zhejiang Yao Yuan Biotechnology Ltd, Jiashan, Zhejiang, China. [6] Duke-NUS Medical School, Singapore. [7] Versiti Blood Research Institute, Milwaukee, WI. [8] Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto, Japan. [9] Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore. [10] Department of Orthopaedic Surgery, National University Health System, Singapore. [11] School of Biological Sciences, Nanyang Technological University, Singapore. [12] Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore. [13] Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [14] NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [15] Harvard Stem Cell Institute, Harvard Medical School, Harvard University, Boston, MA. [16]
DOI 10.1182/blood.2022015830
PMID 36796022
发布时间 2024-03-24
提交
  • 浏览0
Blood

Blood

2023年141卷25期

3078-3090页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷